Cyp76ad1-beta clade polynucleotides, polypeptides, and uses thereof
US-2020354759-A1 · Nov 12, 2020 · US
US11932887B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11932887-B2 |
| Application number | US-202016940666-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 28, 2020 |
| Priority date | Sep 10, 2015 |
| Publication date | Mar 19, 2024 |
| Grant date | Mar 19, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides recombinant polynucleotides comprising a nucleic acid encoding a CYP76AD6 or related gene and their use for producing L-DOPA from tyrosine. The invention also provides recombinant polynucleotides comprising a nucleic acid encoding a CYP76AD1 and/or CYP76AD6, a nucleic acid encoding a DOPA 4,5-dioxygenase (DOD) enzyme, such as Beta vulgaris DODA1, and, in some cases, a nucleic acid encoding betalain related glucosyltransferase, such as Mirabilis. jalapa gene cyclo-DOPA 5-O-glucosyltransferase (cDOPA5GT), and their use for producing betalains. Finally, the invention provides chimeric polypeptides, expression vectors, cells, compositions, and organisms, including plants, and their uses in various methods of the invention.
Opening claim text (preview).
The invention claimed is: 1. A method of producing L-DOPA from tyrosine, comprising: introducing into a cell a recombinant polynucleotide that encodes CYP76AD6, wherein said recombinant polynucleotide is under the control of a heterologous promoter active in said cell, wherein said CYP76AD6 is a tyrosine hydroxylase that converts tyrosine to L-DOPA and comprises the amino acid sequence set forth in SEQ ID NO: 18 and wherein said cell is selected from a plant cell, a bacterial cell and a yeast cell, thereby producing L-DOPA from tyrosine. 2. The method of claim 1 , wherein said method is performed without provision of L-DOPA. 3. The method of claim 1 , wherein said cell is a yeast cell. 4. The method of claim 1 , wherein said cell is a bacterial cell. 5. The method of claim 1 , further comprising introducing into the cell a nucleic acid that increases tyrosine availability in said cell. 6. The method of claim 1 , wherein said cell is a plant cell. 7. The method of claim 1 , wherein said method is performed in culture. 8. The method of claim 1 , wherein said cell is within an organism.
Organic compounds containing hetero rings · CPC title
Organic compounds containing nitrogen · CPC title
Organic compounds; Microorganisms; Enzymes · CPC title
Tyrosine; 3,4-Dihydroxyphenylalanine · CPC title
Human Necessities · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.